Professor Paul Mullan
Co-Investigator | Professor of Molecular Oncology
Dr Paul Mullan is a Professor of Molecular Oncology at the Johnston Cancer Research Centre (JCRC) in Queen’s University Belfast (QUB). Professor Mullan became group leader in 2004, and his multidisciplinary group have a long-standing interest in investigating the molecular pathogenesis of Breast and Ovarian cancers.
Professor Mullan has served on the Scientific Advisory Board of Breast Cancer Now and has acted as advisor to several pharmaceutical companies (including Almac Diagnostics). He is Co-Founder, Director and Chief Scientific Officer of a QUB spin-out company, GenoME Diagnostics, focused on the development of blood based diagnosis and monitoring of cancers. He is scientific lead on a GenoME Diagnostics’ clinical trial to evaluate the utility of a blood test for Ovarian Cancer monitoring.
Since 2013 Professor Mullan has had a growing interest in investigating the potential of aberrant DNA methylation detection using blood sampling. Working closely with the Northern Ireland Biobank, he is Northern Ireland lead for the HEA funded Cancer Liquid Biopsies (CLuB) Consortium, aimed at improving the blood monitoring and diagnosis of multiple aggressive cancer types.